New Trump Travel Ban a Detriment to Biotech
On February 7, 2017, in response to President Trump’s Executive Order on immigration issued on January 27, 2017, approximately 200 senior biotech leaders, including CEOs, company founders and venture capitalists, published a letter in Nature Biotechnology expressing our deep concern about the negative impact this order will have on medical innovation. Following a block by a US federal appeals court, the administration produced a new ban on March 6, which includes changes that remove Iraqis from the list of nationalities affected, exclude current visa holders and refugees already granted asylum, alter the ban on Syrian refugees from indefinite to temporary and implement the ban on March 16 (rather than with immediate effect). Read more
Recent comments on this blog
New Trump Travel Ban a Detriment to Biotech
More on the Shelf
My Biotech Heroes